Topical therapy of psoriasis: Where do we stand?

Topical therapy of psoriasis: Where do we stand?

Bibliographic Details
Main Authors:	D M Thappa, M Malathi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Journal of Postgraduate Medicine
Online Access:	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2017;volume=63;issue=4;spage=210;epage=212;aulast=Thappa

Similar Items

Research on psoriasis in India: Where do we stand?
by: Devinder Mohan Thappa, et al.
Published: (2017-01-01)

Cataract - Where do we stand ?
by: Balasubramanian D
Published: (1997-01-01)

Prolong antiplatelet therapy. Where we stand?
by: Dimitris Tousoulis
Published: (2019-09-01)

Where we stand
by: Luigi Colazzo
Published: (2014-09-01)

Translating tolerogenic therapies to the clinic – where do we stand?
by: Fadi eIssa, et al.
Published: (2012-08-01)

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?
by: Neeta D Gade, et al.
Published: (2013-07-01)

Where we do stand on integrity?
by: Abd Razak, Dzulkifli
Published: (2007)

Flora of Bolivia - where do we stand?
by: RI. Meneses, et al.

Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
by: Inês Barros, et al.
Published: (2020-10-01)

Topical therapies in psoriasis
by: R Torsekar, et al.
Published: (2017-01-01)

Hormone replacement therapy in postmenopause - where we stand?
by: Damir Franić
Published: (2007-02-01)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
by: Chiara Villa
Published: (2020-11-01)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
by: Christopher G Laine, et al.
Published: (2020-01-01)

Genetics of Keratoconus: Where Do We Stand?
by: Khaled K. Abu-Amero, et al.
Published: (2014-01-01)

ColVI myopathies: where do we stand, where do we go?
by: Allamand Valérie, et al.
Published: (2011-09-01)

Cell Therapy for Anal Sphincter Incontinence: Where Do We Stand?
by: Alexandre Balaphas, et al.
Published: (2021-08-01)

Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here
by: Cristina Vassalle, et al.
Published: (2020-06-01)

Trauma Care in Oman: Where do we stand and where should we be heading?
by: Ammar Al-Kashmiri
Published: (2018-01-01)

Alocohol and tobacco consumption : Where do we stand?
by: Shabeena Tawar, et al.
Published: (2014-01-01)

Diabetes Care in Iran: Where We Stand and Where We Are Headed
by: Sina Noshad, et al.
Published: (2016-04-01)

Genetics in Anorexia Nervosa: where we stand and where we are headed
by: Mariana Oliveira Ramos de Castro
Published: (2021)

Preventive psychiatry: Where do we stand?
by: Roy Abraham Kallivayalil, et al.
Published: (2017-01-01)

Myelodysplastic syndromes: Where do we stand?
by: Nitin Sood, et al.
Published: (2016-01-01)

Phytotherapy for Cachexia: Where Do We Stand?
by: Kenny Kuchta, et al.
Published: (2020-07-01)

Knowledge of Anatomy: Where Do we Stand?
by: Muhammad Saeed, et al.
Published: (2009-09-01)

Telemedicine in India: Where do we stand?
by: Vinoth G Chellaiyan, et al.
Published: (2019-01-01)

Cricoid pressure: Where do we stand?
by: Nidhi Bhatia, et al.
Published: (2014-01-01)

Maximizing neuroprotection: where do we stand?
by: Kuffler DP
Published: (2012-04-01)

Hypertension in Oman: Where Do We Stand?
by: Ibrahim Al-Zakwani, et al.
Published: (2018-09-01)

Artificial intelligence: Where do we stand?
by: Alok Chandra Agrawal
Published: (2021-01-01)

Commentary: Retinopathy of prematurity: Where do we stand?
by: Swapnil M Parchand, et al.
Published: (2021-01-01)

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?
by: Gholamreza Davoodi, et al.
Published: (2010-10-01)

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?
by: Mehdi Montazeri, et al.
Published: (2010-11-01)

Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
by: Stephen Paul Cobbold, et al.
Published: (2012-10-01)

mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
by: Aleksandra Kezic, et al.
Published: (2018-01-01)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
by: Jay U Sheth
Published: (2021-01-01)

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
by: Sergio Harari, et al.
Published: (2015-09-01)

Where are we standing in occupational cardiology?
by: Uğur Nadir Karakulak
Published: (2015-09-01)

Recurrent Glioblastoma: Where we stand
by: Sanjoy Roy, et al.
Published: (2015-01-01)

End-of-life palliative chemotherapy: Where do we stand?
by: Amrallah A. Mohammed, et al.
Published: (2015-03-01)